Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

GLAXOSMITHKLINE CONSUMER HEALTHCARE LTD. - (AMALGAMATED)

NSE : NABSE : 500676ISIN CODE : INE264A01014Industry : Consumer FoodHouse : Glaxosmithkline - MNC

BSE10753.650 (0 %)

PREV CLOSE ( ) 10753.65

OPEN PRICE ( ) 10500.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 2533

TODAY'S LOW / HIGH ( )10394.05 10845.75

52 WK LOW / HIGH ( ) 10394.0510845.75

NSE

This Company is not listed in NSE

Select year

(Rs.in Million)

Particulars

Mar 2019

Mar 2018

Mar 2017

Mar 2016

Mar 2015

Profit Before Tax

15122.91

10743.60

10104.16

10559.52

8891.43

Adjustment

-3430.85

-1445.92

-1113.34

-1838.94

-1018.05

Changes In working Capital

13.75

2602.11

1240.57

534.01

1201.33

Cash Flow after changes in Working Capital

11705.81

11899.79

10231.38

9254.59

9074.71

Cash Flow from Operating Activities

6710.68

7230.42

6029.75

5734.59

6114.71

Cash Flow from Investing Activities

-3350.57

-4464.46

-6024.02

-1515.82

3306.86

Cash Flow from Financing Activities

-3767.95

-3634.05

-3613.25

-2855.92

-2221.54

Net Cash Inflow / Outflow

-407.85

-868.09

-3607.53

1362.85

7200.03

Opening Cash & Cash Equivalents

6141.04

7009.13

10616.66

9253.81

2053.78

Cash & Cash Equivalent on Amalgamation / Take over / Merger

Cash & Cash Equivalent of Subsidiaries under liquidations

Translation adjustment on reserves / op cash balalces frgn subsidiaries

Effect of Foreign Exchange Fluctuations

Closing Cash & Cash Equivalent

5733.19

6141.04

7009.13

10616.66

9253.81